⚡ Flash Summary
Citi Pharma Limited (CPHL) has announced the election of directors under Section 159(4) of the Companies Act, 2017. The election will take place during the Annual General Meeting (AGM) scheduled for October 27, 2025. Seven members have filed notices to contest the election, and since this number does not exceed the limit set by the Board of Directors, all named members are deemed elected for the next three-year term. This announcement complies with the Companies Act, 2017, ensuring corporate governance.
📌 Key Takeaways
- 📅 Election of directors announced under Section 159(4) of the Companies Act, 2017.
- 🏢 The announcement is for Citi Pharma Limited (CPHL).
- 🤝 Seven members have filed notices to contest the election.
- 🗳️ The election will occur at the Annual General Meeting (AGM) on October 27, 2025.
- 🕒 AGM is scheduled for 12:30 p.m. at 588 Q Block, Johar Town, Lahore.
- 📜 All seven members are deemed elected as the number does not exceed the board’s limit.
- 🌐 Profiles of the candidates are available on the company’s website (www.citipharma.com.pk).
- ⚖️ The election complies with Section 166 of the Companies Act, 2017.
- 📰 The notice was published in ‘The Nation’ (English) and Nawa-i-waqt (Urdu) on October 20, 2025.
- ⏳ The elected directors will serve a three-year term.
🎯 Investment Thesis
HOLD. Given the nature of the announcement, which is about the election of directors, a HOLD recommendation is appropriate. The election itself does not provide a basis for changing the investment thesis. Monitor the strategic decisions and operational performance of the new board for future reassessment.
Disclaimer: AI-generated analysis. Not financial advice.